DFX Intelligence
Private Equity Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Transactions / G•••••
F•••••••• P••••••• a•• S••••••• E••••• Make Growth Investment in G•••••
Growth investmentannouncedannouncement date unknownFact
What happened
- Target
- G•••••
- Platform
- not an add-on on record
- Control
- unknown
- Share acquired
- unknown
- Industry
- unknown
- Target location
- unknown
- Seller kind
- unknown
- Rollover
- unknown
Values, only where disclosed
- Enterprise value
- Not disclosed
- Purchase price
- Not disclosed
- Equity value
- Not disclosed
- Target revenue
- Not disclosed
- Target EBITDA
- Not disclosed
- Multiple
- Not disclosed
Parties and roles
5 named
Buy side
- ““G••••• sits at the intersection of two healthcare megatrends: the ‘consumerization’ of healthcare and demand for greater price transparency,” said C•••• A••••, Partner at F•••••••• Partners.”
- “F•••••••• Partners is a leading global private equity firm, which specializes in investments in technology and technology-enabled services businesses.”
Side not stated
- “"We are proud to offer solutions that help Americans afford life-saving medications,” said D••• H•••••, co-CEO of G•••••.”
- ““The expertise and resources of F•••••••• P••••••• a•• S••••••• E••••• will enable G••••• to provide information and savings to even more Americans,” added T••••• B•••••, co-CEO of G•••••.”
- “G•••••, America’s leading prescription price transparency platform, today announced an investment from F•••••••• P••••••• a•• S••••••• E•••••.”
Evidence
“G•••••, America’s leading prescription price transparency platform, today announced an investment from F•••••••• P••••••• a•• S••••••• E•••••.”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026